Laurion Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-700,000
| Closed | -$37.8M | – | 377 |
|
|
2025
Q4 | $37.8M | Buy |
+700,000
| New | +$33.7M | 1.41% | 19 |
|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$2.71M | – | 572 |
|
|
2024
Q1 | $2.71M | Sell |
50,000
-331,300
| -87% | -$16.9M | 0.02% | 317 |
|
|
2023
Q4 | $19.6M | Hold |
381,300
| – | – | 0.17% | 119 |
|
|
2023
Q3 | $22.1M | Sell |
381,300
-350,000
| -48% | -$21.4M | 0.14% | 135 |
|
|
2023
Q2 | $46.8M | Buy |
731,300
+600,000
| +457% | +$40.2M | 0.26% | 90 |
|
|
2023
Q1 | $9.1M | Buy |
+131,300
| New | +$9.26M | 0.06% | 201 |
|
|
2022
Q4 | – | Sell |
-500,000
| Closed | -$35.5M | – | 425 |
|
|
2022
Q3 | $35.5M | Sell |
500,000
-390,000
| -44% | -$28.3M | 0.21% | 100 |
|
|
2022
Q2 | $68.5M | Buy |
+890,000
| New | +$67.8M | 1.06% | 19 |
|
|
2022
Q1 | – | Sell |
-9,000
| Closed | -$561K | – | 548 |
|
|
2021
Q4 | $561K | Sell |
9,000
-69,000
| -88% | -$4.05M | 0.01% | 407 |
|
|
2021
Q3 | $4.62M | Buy |
+78,000
| New | +$5.14M | 0.02% | 351 |
|
|
2020
Q3 | – | Sell |
-69,200
| Closed | -$4.07M | – | 851 |
|
|
2020
Q2 | $4.07M | Sell |
69,200
-153,700
| -69% | -$9.19M | 0.05% | 246 |
|
|
2020
Q1 | $12.4M | Buy |
222,900
+32,900
| +17% | +$2.01M | 0.14% | 150 |
|
|
2019
Q4 | $12.2M | Sell |
190,000
-257,500
| -58% | -$14.7M | 0.09% | 193 |
|
|
2019
Q3 | $22.7M | Buy |
+447,500
| New | +$21M | 0.17% | 134 |
|
|
2018
Q4 | – | Sell |
-750,100
| Closed | -$46.6M | – | 1121 |
|
|
2018
Q3 | $46.6M | Buy |
+750,100
| New | +$44.5M | 0.45% | 27 |
|
|
2017
Q4 | – | Sell |
-77,500
| Closed | -$4.94M | – | 1541 |
|
|
2017
Q3 | $4.94M | Sell |
77,500
-89,500
| -54% | -$5.23M | 0.02% | 515 |
|
|
2017
Q2 | $9.3M | Buy |
167,000
+110,100
| +193% | +$5.99M | 0.05% | 337 |
|
|
2017
Q1 | $3.1M | Buy |
56,900
+54,800
| +2,610% | +$3.01M | 0.02% | 520 |
|
|
2016
Q4 | $123K | Buy |
+2,100
| New | +$115K | ﹤0.01% | 1046 |
|
|
2016
Q2 | – | Sell |
-600,000
| Closed | -$38.3M | – | 826 |
|
|
2016
Q1 | $38.3M | Buy |
+600,000
| New | +$37.8M | 0.61% | 38 |
|
|
2015
Q4 | – | Sell |
-80,000
| Closed | -$4.74M | – | 883 |
|
|
2015
Q3 | $4.74M | Buy |
+80,000
| New | +$5.08M | 0.06% | 250 |
|
|
2014
Q3 | – | Sell |
-580,000
| Closed | -$28.1M | – | 302 |
|
|
2014
Q2 | $28.1M | Buy |
580,000
+245,000
| +73% | +$12.1M | 0.59% | 50 |
|
|
2014
Q1 | $17.4M | Buy |
335,000
+301,800
| +909% | +$16.1M | 0.64% | 57 |
|
|
2013
Q4 | $1.76M | Sell |
33,200
-81,900
| -71% | -$4.17M | 0.06% | 118 |
|
|
2013
Q3 | $5.33M | Buy |
+115,100
| New | +$5.05M | 0.39% | 70 |
|
Other funds holding BMY
VCM
VPM
Laurion Capital Management's BMY Position: Q1 2026 in Review
Laurion Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 36,100 shares worth $2.19M. The stake represents 0.1% of the portfolio and ranks #202 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in BMY as recently as Q2 2024.
Laurion Capital Management first reported a position in BMY in Q3 2013 and has held it in 26 quarters since. The position peaked at $176M in Q1 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Laurion Capital Management held 36,100 shares of Bristol-Myers Squibb worth $2.19M as of Q1 2026.
- Bristol-Myers Squibb was a new Laurion Capital Management position in Q1 2026.
- Bristol-Myers Squibb made up 0.1% of Laurion Capital Management's portfolio in Q1 2026, its #202 holding.
- Laurion Capital Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 26 quarters since.
- Laurion Capital Management's Bristol-Myers Squibb position peaked at $176M in Q1 2020.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.